Physician

Murtaza Khuzema Adam, MD

According to 2025 Medicare claims, Murtaza Adam, MD (NPI: 1093004806) practices ophthalmology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Denver, CO. This provider's primary affiliated billing organization is COLORADO RETINA ASSOCIATES, PLLC (NPI: 1790876159; TIN: 203288374) and primary practice location at 80134-5640.

Adam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,061 traditional Medicare patients, billed 42,834 HCPCS/CPT codes, and received $3,257,889 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 986 prescription claims across 397 beneficiaries totaling $32,406 in drug costs, led by Ketorolac Tromethamine (Ketorolac Tromethamine). Open Payments data shows 200 records totaling $408,805. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $98,474 to $3,257,889. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $31,621 and ending at $32,406. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	311	811	$98,474
2016	491	1,096	$149,048
2017	375	985	$98,427
2018	688	7,634	$1,229,153
2019	749	8,228	$1,692,168
2020	874	8,543	$1,637,514
2021	910	9,428	$2,089,283
2022	1,068	9,715	$2,067,364
2023	1,004	26,684	$2,461,339
2024	1,061	42,834	$3,257,889

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	149	551	$31,621
2016	201	513	$27,883
2017	153	381	$18,477
2018	139	388	$20,684
2019	176	601	$31,597
2020	229	724	$35,602
2021	298	1,001	$52,618
2022	361	988	$55,028
2023	366	903	$45,833
2024	397	986	$32,406

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	330	1,525	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	202	258	$102
92014	Established patient complete exam of visual system	630	751	$97
99426	Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month	191	1,067	$52
92134	Imaging of retina	1,024	2,644	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ketorolac Tromethamine	Ketorolac Tromethamine	212	11,098	$7,885
Difluprednate	Difluprednate	44	1,716	$5,195
Prednisolone Acetate	Prednisolone Acetate	110	5,266	$4,439
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	253	5,874	$2,979
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	96	8,114	$1,047

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	145	$170,812	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	55	$237,993	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Murtaza Khuzema Adam, MD?

Tedicare shows public-source Medicare data for Murtaza Khuzema Adam, MD (NPI 1093004806), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Murtaza Khuzema Adam, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Murtaza Khuzema Adam, MD?

Murtaza Khuzema Adam, MD is linked to COLORADO RETINA ASSOCIATES, PLLC (billing NPI 1790876159) in the available physician profile data.

Does Murtaza Khuzema Adam, MD have Open Payments data?

Murtaza Khuzema Adam, MD has 200 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.